Literature DB >> 10987903

Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis.

M Cheung1, A S Chan, S C Law, J H Chan, V K Tse.   

Abstract

BACKGROUND: Radiotherapy is the primary treatment for nasopharyngeal carcinoma, and temporal lobe necrosis is observed in about 7% of patients after radiotherapy. Although some studies reported that these patients demonstrated cognitive impairment after radiotherapy, it is still unclear if the cognitive deficits are related to the radiation exposure or the radiation-induced necrosis.
OBJECTIVE: To compare the cognitive function of patients with and without temporal lobe necrosis after radiotherapy for nasopharyngeal carcinoma.
METHODS: A comprehensive neuropsychological battery was administered to 53 patients with nasopharyngeal carcinoma who had completed their radiotherapy at least 1 year previously. As evidenced by magnetic resonance imaging, 31 patients developed necrosis after treatment. Thirty-one age- and education-matched individuals were recruited as normal control subjects.
RESULTS: Whereas the performance of patients without temporal lobe necrosis was similar to that of normal control subjects, patients with temporal lobe necrosis demonstrated significant impairment on tests of verbal (P<.001) and visual memory (range, P<.001 to P =.03), language (range, P<.001 to P =.01), motor ability (P =.02), planning (P =.02), cognitive ability (P =.007), and abstract thinking (range, P =.009 to P =.04). However, the performance of patients with necrosis on tests of general intelligence (range, P =.08 to P =.15), attention (range, P =.06 to P =.55), and visual abilities (range, P =.06 to P =.47) was not significantly different from that of normal control subjects and patients without necrosis.
CONCLUSIONS: Radiotherapy for nasopharyngeal carcinoma seemed to have adverse but insignificant effects on the cognitive functions of the patients. However, for patients who developed temporal lobe necrosis after radiotherapy, memory, language, motor ability, and executive functions were significantly impaired, although their general intelligence remained relatively intact.

Entities:  

Mesh:

Year:  2000        PMID: 10987903     DOI: 10.1001/archneur.57.9.1347

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  31 in total

Review 1.  Treatment of radiation-induced cognitive decline.

Authors:  Albert Attia; Brandi R Page; Glenn J Lesser; Michael Chan
Journal:  Curr Treat Options Oncol       Date:  2014-12

2.  Late Temporal Lobe Extensive Osteoradionecrosis Post Radiation for Nasopharyngeal Carcinoma: Case Series.

Authors:  Chian Ling Tang; Ramesh Kumar; Charng Jeng Toh; Shahizon Azura; Geok Chin Tan; Balwant Singh Gendeh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-09-22

3.  Radiation-induced brain structural and functional abnormalities in presymptomatic phase and outcome prediction.

Authors:  Zhongxiang Ding; Han Zhang; Xiao-Fei Lv; Fei Xie; Lizhi Liu; Shijun Qiu; Li Li; Dinggang Shen
Journal:  Hum Brain Mapp       Date:  2017-10-23       Impact factor: 5.038

4.  A retrospective study of salvage surgery for recurrent nasopharyngeal carcinoma.

Authors:  Xue Bian; Hui Chen; Lianming Liao
Journal:  Int J Clin Oncol       Date:  2011-06-29       Impact factor: 3.402

5.  Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.

Authors:  Christopher R Peeler; Dragan Mirkovic; Uwe Titt; Pierre Blanchard; Jillian R Gunther; Anita Mahajan; Radhe Mohan; David R Grosshans
Journal:  Radiother Oncol       Date:  2016-11-16       Impact factor: 6.280

6.  Caregiver-reported neuropsychiatric symptoms in patients undergoing treatment for head and neck cancer: a pilot study.

Authors:  Stewart M Bond; Deborah K Hawkins; Barbara A Murphy
Journal:  Cancer Nurs       Date:  2014 May-Jun       Impact factor: 2.592

7.  Current management strategy of nasopharyngeal carcinoma.

Authors:  William I Wei; Dora L W Kwong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

8.  Structural MRI research in patients with nasopharyngeal carcinoma following radiotherapy: A DTI and VBM study.

Authors:  Xi Leng; Peng Fang; Huan Lin; Jie An; Xin Tan; Chi Zhang; Donglin Wu; Wen Shen; Shijun Qiu
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

9.  Neurocognitive function in patients with head and neck cancer undergoing primary or adjuvant chemoradiation treatment.

Authors:  Stewart M Bond; Mary S Dietrich; Jill Gilbert; E Wesley Ely; James C Jackson; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2016-05-25       Impact factor: 3.603

10.  Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  B Khodayari; A L Michaud; S Stanic; O H Wooten; A Dublin; J A Purdy; A M Chen
Journal:  Br J Radiol       Date:  2014-03-13       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.